Septanazal for children nasal spray 0.5mg/50mg/1ml 10ml №1

NameSeptanasal for children. Release form Dosed nasal spray. INNK silometazoline + dexpanthenol. FTGS Means for the treatment of diseases of the nose. Composition 1 ml nasal spray contains 0.5 mg xylometazoline hydrochloride and 50 mg dexpanthenol. 1 single-pressure dose is 0.1 ml nasal spray and contains 0.05 mg xylometazoline hydrochloride and 5.0 mg dexpanthenol. Excipients: potassium dihydrogen phosphate, disodium phosphate dodecahydrate, purified water. Classification code Sympathomimetics, combinations, excluding corticosteroids. ATX code: R01AB06. Pharmacological properties SeptaNazal® for children is a nasal spray containing the active substances xylometazoline hydrochloride and dexpanthenol. Xylometazoline hydrochloride has a vasoconstrictive effect, thus eliminating swelling of the nasal mucosa. Dexpanthenol – a vitamin of group B, a derivative of pantothenic acid, has a protective effect and promotes the healing of mucosal lesions. Indications for use The drug is recommended: to reduce swelling of the nasal mucosa in acute respiratory diseases with symptoms of rhinitis (runny nose) and as a supportive treatment for the healing of damage to the nasal mucosa, to alleviate the condition with vasomotor rhinitis, to restore nasal breathing after surgery in the nasal cavity . The drug is recommended for children from 2 years. Method of application and dosage Intranasally. Children from 2 to 6 years old – one injection of SeptaNazal® for children in each nasal passage up to 3 times a day. For children over 6 years old, SeptaNazal® nasal spray for adults is recommended, containing a higher dose of the active substance. Dosing depends on individual sensitivity and clinical efficacy. Do not use the drug for more than 7 days. A second course is possible after a break of several days. How to use Remove the protective cap from the sprayer. Before the first use, and also if the spray has not been used for a long period of time, press the sprayer several times until the optimum flow appears. The upper part (tip) of the nebulizer should be inserted as vertically as possible into the nasal passage and the nebulizer should be pressed once. At the time of injection, the patient should take a light breath through the nose. If necessary, the procedure should be repeated with another nasal passage. After each use, the spray tip should be wiped with a paper towel and capped. Long-term use of high doses of the drug can lead to chronic edema and subsequent atrophy of the nasal mucosa. In case of increased intraocular pressure (glaucoma), especially angle-closure glaucoma, you should consult your doctor before use. Ingestion with food and drink The drug can be taken with or without food. In case of missing the next dose of the drug Do not take a double dose in order to make up for the missed one. Stopping the use of the drug You can stop using the drug at any time convenient for you. If you need more information or advice, ask your doctor or pharmacist. Side effects Like any drug, in rare cases, the drug can cause side effects. Classification of the incidence of side effects according to the World Health Organization: very common (≥1/10) frequent (≥1/100 to <1/10) - infrequent (≥1/1000 to <1/100) rare (≥1/10000 to < 1/1000) very rare (< 1/10000) frequency not known (cannot be estimated from the available data). Infrequent: hypersensitivity reactions (skin rash, itching, swelling of the skin and mucous membranes). Rare: palpitations, tachycardia, hypertension. Very rare: agitation, insomnia, fatigue, headache, hallucinations (mainly in children); arrhythmia; swelling of the nasal mucosa (after discontinuation of treatment), epistaxis; convulsions (mainly in children). Frequency unknown (cannot be estimated from the available data): burning and dryness of the nasal mucosa, sneezing. If you experience adverse reactions, including those not listed in the leaflet, please consult your doctor. Contraindications Hypersensitivity to active substances or to any of the excipients of the drug. Dry inflammation of the nasal mucosa. Surgical removal of the pituitary gland or other surgical interventions on the meninges (history). SeptaNazal® for children is contraindicated in children under 2 years of age. Overdose When applied intranasally, systemic exposure is unlikely, since local narrowing of the lumen of blood vessels leads to a decrease in absorption. If the recommended doses are exceeded or if large amounts of the drug are accidentally taken orally (by mouth), the following undesirable effects are possible: pupillary constriction (miosis), pupillary dilation (mydriasis), fever, increased sweating, pallor of the skin, bluish color of the lips (cyanosis), nausea , convulsions, disorders of the cardiovascular system (increase or decrease in heart rate, cardiac arrhythmias, cardiac arrest, hypertension), respiratory disorders (pulmonary edema, impaired respiratory function), mental disorders. In addition, if the recommended doses are exceeded or if large amounts of the drug are accidentally taken orally (orally), drowsiness, a decrease in body temperature, a decrease in blood pressure, impaired respiratory function and coma are possible. If any of these symptoms appear, you should immediately consult a doctor. Precautions: Consult your doctor before use: if the patient is receiving therapy with monoamine oxidase inhibitors (MAOIs) and other drugs that potentially increase blood pressure, with increased intraocular pressure (glaucoma), especially angle-closure glaucoma, with severe diseases of the heart and circulatory organs (for example, coronary heart disease, high blood pressure), pheochromocytoma, metabolic disorders (eg, hyperthyroidism, diabetes), porphyria, prostatic hyperplasia. The use of the drug in the case of chronic rhinitis is possible only under the supervision of a physician, since there is a possibility of developing atrophy of the nasal mucosa. Incorrect use and overdose of the drug can lead to the manifestation of side effects, especially in children. It is not recommended to take the spray simultaneously with: medicines for the treatment of influenza, medicines for the common cold and cough containing sympathomimetics (for example, pseudoephedrine, ephedrine, phenylephrine, oxymetazoline, xylometazoline, tramazolin, naphazoline, that aminoheptane). With concomitant use, the risk of side effects from the cardiovascular and central nervous systems increases. Avoid getting the drug in the eyes. Use in children Do not exceed recommended doses. It is recommended to consult a doctor regarding therapy and dosing features in children. SeptaNazal® for children is intended for children from 2 to 6 years of age. For children over 6 years of age, SeptaNazal® for adults is recommended, containing a higher dose of the active substance. The use of the drug in children should be under the supervision of adults. If after 3 days of treatment there is no improvement in the child's condition, or the child feels worse, a doctor should be consulted. Pregnancy and lactation During pregnancy and lactation, you should consult your doctor before taking any medications. It is not recommended to use the drug during pregnancy due to the lack of sufficient safety data. It is not recommended to use the drug during lactation, since it is not known whether xylometazoline hydrochloride is excreted in breast milk. Influence on the ability to drive a car or other mechanisms When used in accordance with the recommendations, the drug does not affect the ability to drive vehicles and work with complex mechanisms. Interaction with other medicinal products Before you start taking it, you must tell your doctor that you are taking or have recently taken any medicines. The concomitant use of drugs for the treatment of depression (tranylcypromine-type monoamine oxidase inhibitors or tricyclic antidepressants), as well as drugs that increase blood pressure, can lead to an increase in blood pressure. With simultaneous use with drugs for the treatment of influenza, as well as sympathomimetics contained in cold and cough medicines (for example, pseudoephedrine, ephedrine, phenylephrine, oxymetazoline, xylometazoline, tramazoline, naphazoline, tuaminoheptane), the risk of side effects from the side of cardio- vascular and central nervous systems. Conditions and period of storageBefore opening the vial Does not require special storage conditions. After opening the vial, store at a temperature not exceeding 25°C. Keep out of the reach of children. Shelf life 2 years. After opening the vial, the drug should be used within 3 months. Do not use after the expiry date stated on the packaging. The expiration date refers to the last day of the month. Holiday conditions Without a doctor's prescription. Packaging White plastic bottle (HDPE) with white pump and red plastic cap: 10 ml nasal spray, in box, with leaflet. 10 ml nasal spray corresponds to 100 sprays. Buy Septanazal for children nasal spray 0.5mg/50mg/1ml 10ml №1 ,5mg/50mg/1ml 10ml №1